Im Cannabis Corp Stock Today
| IMCC Stock | USD 1.74 0.09 4.92% |
PerformanceVery Weak
| Odds Of DistressVery High
|
Im Cannabis is trading at 1.74 as of the 19th of March 2025, a 4.92% down since the beginning of the trading day. The stock's open price was 1.83. Im Cannabis has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 19th of December 2024 and ending today, the 19th of March 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 20th of May 2020 | Category Healthcare | Classification Health Care |
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. The company serves medical patients and adult-use recreational consumers. IM Cannabis is traded on NASDAQ Exchange in the United States. The company has 3.09 M outstanding shares of which 6.46 K shares are currently shorted by private and institutional investors with about 0.78 trading days to cover. More on Im Cannabis Corp
Moving together with IMCC Stock
Moving against IMCC Stock
IMCC Stock Highlights
| Executive Chairman | MSc MBA | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsIm Cannabis can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Im Cannabis' financial leverage. It provides some insight into what part of Im Cannabis' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Im Cannabis Corp (IMCC) is traded on NASDAQ Exchange in USA. It is located in Kibbutz Glil Yam, Tel Aviv, Israel, 4690500 and employs 95 people. Im Cannabis is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 5.85 M. Im Cannabis Corp conducts business under Biotechnology sector and is part of Health Care industry. The entity has 3.09 M outstanding shares of which 6.46 K shares are currently shorted by private and institutional investors with about 0.78 trading days to cover.
Im Cannabis Corp currently holds about 5.86 M in cash with (8.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.08.
Check Im Cannabis Probability Of Bankruptcy
Ownership AllocationIm Cannabis shows considerable amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares.
Check IMCC Ownership Details
IMCC Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Renaissance Technologies Corp | 2024-09-30 | 0.0 | |
| Morgan Stanley - Brokerage Accounts | 2024-09-30 | 0.0 | |
| Advisorshares Investments, Llc | 2024-12-31 | 104.1 K | |
| Bank Of Montreal | 2024-12-31 | 12.6 K | |
| Bmo Capital Markets Corp. | 2024-12-31 | 12.6 K | |
| Federation Des Caisses Desjardins Du Quebec | 2024-12-31 | 3.8 K | |
| Royal Bank Of Canada | 2024-12-31 | 290 | |
| Bryn Mawr Trust Company | 2024-12-31 | 9.0 | |
| Sbi Securities Co Ltd | 2024-12-31 | 8.0 | |
| Td Waterhouse Canada Inc | 2024-12-31 | 3.0 | |
| Group One Trading, Lp | 2024-12-31 | 2.0 |
Im Cannabis Historical Income Statement
IMCC Stock Against Markets
Im Cannabis Corporate Management
| Shai Shemesh | Chief Officer | Profile | |
| Advocate Nissimov | General Counsel | Profile | |
| Michael Ruscetta | Chief Corp | Profile | |
| Richard Balla | Chief Adjupharm | Profile | |
| Rinat Efrima | Chief Israel | Profile | |
| Howard CFA | Chief MYM | Profile |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Im Cannabis Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Im Cannabis. If investors know IMCC will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Im Cannabis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.02) | Revenue Per Share | Quarterly Revenue Growth 0.122 | Return On Assets | Return On Equity |
The market value of Im Cannabis Corp is measured differently than its book value, which is the value of IMCC that is recorded on the company's balance sheet. Investors also form their own opinion of Im Cannabis' value that differs from its market value or its book value, called intrinsic value, which is Im Cannabis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Im Cannabis' market value can be influenced by many factors that don't directly affect Im Cannabis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Im Cannabis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Im Cannabis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Im Cannabis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.